Clinical Trial

Dopamine and Sensorimotor Function in Stuttering

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated October 14, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.
Trial Details
NCT Number NCT07215884
Lead Sponsor University of California, San Francisco
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD), University of Washington
Conditions Stuttering, Adult
Enrollment 40 participants
Start Date 2025-09-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-14